Literature DB >> 8560532

Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro.

P Brasseur1, P Agnamey, A S Ekobo, G Samba, L Favennec, J Kouamouo.   

Abstract

A comparative study in vivo of amodiaquine efficacy (35 mg/kg over 3 d) and chloroquine (25 mg/kg over 3 d) was conducted in 1991 and 1992 in Cameroon and Congo in 123 patients with uncomplicated Plasmodium falciparum malaria. Amodiaquine was more effective than chloroquine, with parasite clearance by day 7 in 79.7% of the patients compared with 59.4%. Sixteen of 32 (50%) P. falciparum isolates tested in vitro were resistant to chloroquine and only 3 of 34 (9%) were resistant to amodiaquine. 5.3% of patients treated with amodiaquine complained of pruritus and 18.7% of nausea, compared with 15.7% and 5% respectively of those treated with chloroquine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560532     DOI: 10.1016/0035-9203(95)90096-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo.

Authors:  Bruno Pradines; Philippe Hovette; Thierry Fusai; Henri Léonard Atanda; Eric Baret; Philippe Cheval; Joel Mosnier; Alain Callec; Julien Cren; Rémy Amalvict; Jean Pierre Gardair; Christophe Rogier
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro.

Authors:  S T Mariga; J P Gil; C Sisowath; W H Wernsdorfer; A Björkman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo.

Authors:  Ingrid van den Broek; Christa Kitz; Sarwatt Al Attas; François Libama; Manica Balasegaram; Jean-Paul Guthmann
Journal:  Malar J       Date:  2006-11-24       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.